ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BIAL and Medis entered into a partnership for innovative medicines for the central nervous system
July 20, 2021BIAL and Medis, d.o.o. announce that they have entered into an exclusive partnership on two BIAL's proprietary drugs: Zebinix® (eslicarbazepine acetate) and Ongentys® (opicapone). -
Teva attracts attention from pharma, private equity for $500M sale of Medis
September 14, 2018Teva has been working to pay down tens of billions of dollars of debt since it purchased Allergan’s generics suite for more than $40 billion. Now, the company's Medis unit has attracted attention from industry players and private equity firms, according t
Pharma Sources Insight January 2025
